Ritchie H, Jamieson A, Booth N A
Department of Molecular and Cell Biology, University of Aberdeen, UK.
Thromb Haemost. 1995 Dec;74(6):1521-7.
Fibrin deposition is a characteristic feature of the atherosclerotic plaque. The balance of fibrinolytic activity is modulated by plasminogen activators (PAs) and plasminogen activator inhibitors (PAIs). We examined expression of components of the fibrinolytic system by peripheral blood monocytes following stimulation by native LDL and LDL modified by acetylation, copper oxidation or minimal modification. Monocytes responded to LDL stimulation by increased production of PAI-2, with no corresponding increase in u-PA. PAI-1 was detected but did not change relative to untreated control; u-PA was undetectable in all samples. Native LDL consistently upregulated PAI-2; this stimulation was not inhibited by inclusion of antioxidants. Acetylated, copper oxidized and minimally modified LDLs increased production of PAI-2, but the ability to stimulate PAI-2 synthesis varied between preparations of modified LDL. Increased levels of PAI-2 in a local environment such as the artery wall may promote fibrin persistence.
纤维蛋白沉积是动脉粥样硬化斑块的一个特征性表现。纤溶活性的平衡由纤溶酶原激活剂(PAs)和纤溶酶原激活剂抑制剂(PAIs)调节。我们检测了天然低密度脂蛋白(LDL)以及经乙酰化、铜氧化或轻微修饰的LDL刺激后外周血单核细胞中纤溶系统各成分的表达。单核细胞对LDL刺激的反应是PAI-2产生增加,而尿激酶型纤溶酶原激活剂(u-PA)没有相应增加。检测到了PAI-1,但相对于未处理的对照没有变化;所有样本中均未检测到u-PA。天然LDL持续上调PAI-2;这种刺激不受抗氧化剂的抑制。乙酰化、铜氧化和轻微修饰的LDL增加了PAI-2的产生,但不同制备的修饰LDL刺激PAI-2合成的能力有所不同。在动脉壁等局部环境中PAI-2水平升高可能会促进纤维蛋白的持续存在。